These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37053274)

  • 1. Role of the Microbiome in Gut-Heart-Kidney Cross Talk.
    Glorieux G; Nigam SK; Vanholder R; Verbeke F
    Circ Res; 2023 Apr; 132(8):1064-1083. PubMed ID: 37053274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.
    Vanholder R; Nigam SK; Burtey S; Glorieux G
    Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
    Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
    Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote effects of kidney drug transporter OAT1 on gut microbiome composition and urate homeostasis.
    Ermakov VS; Granados JC; Nigam SK
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective.
    Lohia S; Vlahou A; Zoidakis J
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic anion transporters in remote sensing and organ crosstalk.
    Granados JC; Nigam SK
    Pharmacol Ther; 2024 Nov; 263():108723. PubMed ID: 39284369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives.
    Caggiano G; Stasi A; Franzin R; Fiorentino M; Cimmarusti MT; Deleonardis A; Palieri R; Pontrelli P; Gesualdo L
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
    Suganya K; Son T; Kim KW; Koo BS
    Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Link between gut microbiota dysbiosis and chronic kidney disease.
    Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.
    Nigam SK; Bush KT
    Nat Rev Nephrol; 2019 May; 15(5):301-316. PubMed ID: 30728454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.
    Mitrea L; Medeleanu M; Pop CR; Rotar AM; Vodnar DC
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome in Chronic Kidney Disease.
    Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
    Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
    Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
    Lau WL; Savoj J; Nakata MB; Vaziri ND
    Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.